steady state for modified release [Regulatives / Guidelines]

posted by Kelen – Brazil, 2019-09-20 20:04 (1057 d 14:34 ago) – Posting: # 20636
Views: 4,619

I would like to ask help for understand the objetive of the steady state study when you are comparing a MR formulation with a IR formulation. The objective would be compare the effect of the accumulation? Is there any reason to conduct the study only with de highest dose?


Edit: Please follow the Forum’s Policy[Helmut]

Complete thread:

UA Flag
Activity
 Admin contact
22,301 posts in 4,667 threads, 1,585 registered users;
online 5 (0 registered, 5 guests [including 2 identified bots]).
Forum time: Saturday 10:38 CEST (Europe/Vienna)

In the field of observation,
chance favors only the mind that is prepared.    Louis Pasteur

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5